GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4SC AG (LTS:0R6U) » Definitions » Interest Expense

4SC AG (LTS:0R6U) Interest Expense : €-0.10 Mil (TTM As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is 4SC AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. 4SC AG's interest expense for the six months ended in Dec. 2023 was € -0.08 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.10 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. 4SC AG's Operating Income for the six months ended in Dec. 2023 was € -3.62 Mil. 4SC AG's Interest Expense for the six months ended in Dec. 2023 was € -0.08 Mil. 4SC AG did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


4SC AG Interest Expense Historical Data

The historical data trend for 4SC AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4SC AG Interest Expense Chart

4SC AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.04 - - -0.10

4SC AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -0.03 -0.08

4SC AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4SC AG  (LTS:0R6U) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

4SC AG's Interest Expense for the six months ended in Dec. 2023 was €-0.08 Mil. Its Operating Income for the six months ended in Dec. 2023 was €-3.62 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was €0.00 Mil.

4SC AG's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

4SC AG did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


4SC AG (LTS:0R6U) Business Description

Traded in Other Exchanges
Address
Fraunhoferstraße 22, Planegg-Martinsried, DEU, 82152
4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. It Geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.

4SC AG (LTS:0R6U) Headlines

No Headlines